Clinical Trials Logo

Healthy Adult Male clinical trials

View clinical trials related to Healthy Adult Male.

Filter by:
  • None
  • Page 1

NCT ID: NCT05439148 Completed - Healthy Adult Male Clinical Trials

OPC-61815 in Healthy Chinese Male Subjects

Start date: June 30, 2022
Phase: Phase 1
Study type: Interventional

To evaluate the pharmacokinetic (PK) characteristics and pharmacological effect of OPC-61815 in healthy Chinese Male subjects

NCT ID: NCT04415645 Completed - Healthy Adult Male Clinical Trials

Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects

Start date: February 24, 2020
Phase: Phase 1
Study type: Interventional

This is an open-label, single-dose, absorption, metabolism, excretion, and mass balance study following a single IV infusion of [14C]-VVZ-149 in healthy adult male subjects. Whole blood, plasma, urine, and fecal samples will be analyzed for at least 72 hours following the start of infusion to measure total radioactivity and plasma drug concentrations.

NCT ID: NCT04182958 Completed - Healthy Adult Male Clinical Trials

A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects

Start date: November 25, 2019
Phase: Phase 1
Study type: Interventional

- To determine the mass balance of totalradioactivity following a single IV infusionof (14C)-OPC-61815. - To determine routes and rates of elimination of total radioactivity following a single IV infusion of (14C)-OPC-61815 - To assess the PK of total radioactivity in plasma and whole blood following a single IV infusion of (14C)-OPC-61815 - To assess the PK of OPC-61815 free form and OPC-41061 in plasma following a single IV infusion of (14C)-OPC-61815

NCT ID: NCT03902574 Completed - Healthy Adult Male Clinical Trials

Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg

Start date: March 27, 2019
Phase: Phase 1
Study type: Interventional

To investigate the bioequivalence of brexpiprazole ODT 2 mg and brexpiprazole conventional tablet 2 mg

NCT ID: NCT02994394 Completed - Healthy Adult Male Clinical Trials

A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects

Start date: January 6, 2017
Phase: Phase 1
Study type: Interventional

To assess the bioequivalence of OPC-41061 OD tablets and OPC-41061 conventional tablets at 15 and 30 mg in healthy adult male subjects.

NCT ID: NCT02875080 Completed - Healthy Adult Male Clinical Trials

Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects

Start date: September 27, 2016
Phase: Phase 1
Study type: Interventional

The ratios of the geometric means of the ODT formulation to those of the reference formulation (conventional tablet) for the bioavailability variables (Cmax, AUCt, and AUC∞ of brexpiprazole (OPC-34712)).

NCT ID: NCT01423435 Completed - Healthy Adult Male Clinical Trials

Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males

Start date: August 2011
Phase: Phase 1
Study type: Interventional

A study to evaluate the pharmacokinetics and safety of TRK-100STP in Japanese, Chinese, and South Korean non-elderly healthy adult males.

NCT ID: NCT01258699 Completed - Healthy Adult Male Clinical Trials

A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects

Start date: August 2009
Phase: Phase 1
Study type: Interventional

This study is Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects.